![]() 反式-4-(马来酰亚胺甲基)环己烷羧酸-NHS结构式
![]() |
常用名 | 反式-4-(马来酰亚胺甲基)环己烷羧酸-NHS | 英文名 | Trans-4-(Maleimidomethyl)cyclohexanecarboxylic Acid-NHS |
---|---|---|---|---|
CAS号 | 71875-81-5 | 分子量 | 334.324 | |
密度 | 1.4±0.1 g/cm3 | 沸点 | 501.7±42.0 °C at 760 mmHg | |
分子式 | C16H18N2O6 | 熔点 | N/A | |
MSDS | N/A | 闪点 | 257.2±27.9 °C |
中文名 | 反式-4-(马来酰亚胺甲基)环己烷羧酸-NHS |
---|---|
英文名 | 1-[(trans-4-{[(2,5-Dioxo-1-pyrrolidinyl)oxy]carbonyl}cyclohexyl)m ethyl]-1H-pyrrole-2,5-dione |
英文别名 | 更多 |
密度 | 1.4±0.1 g/cm3 |
---|---|
沸点 | 501.7±42.0 °C at 760 mmHg |
分子式 | C16H18N2O6 |
分子量 | 334.324 |
闪点 | 257.2±27.9 °C |
精确质量 | 334.116486 |
PSA | 101.06000 |
LogP | -0.39 |
蒸汽压 | 0.0±1.3 mmHg at 25°C |
折射率 | 1.598 |
储存条件 | -20°C |
海关编码 | 2925190090 |
---|
~% 反式-4-(马来酰亚胺甲基)环... 71875-81-5 |
文献:Kimura, Sadaaki; Masunaga, Shin-Ichiro; Harada, Tomohiro; Kawamura, Yasuo; Ueda, Satoshi; Okuda, Kensuke; Nagasawa, Hideko Bioorganic and Medicinal Chemistry, 2011 , vol. 19, # 5 p. 1721 - 1728 |
~89% 反式-4-(马来酰亚胺甲基)环... 71875-81-5 |
文献:Paterson, Michael J.; Eggleston, Ian M. Synthetic Communications, 2008 , vol. 38, # 2 p. 303 - 308 |
~% 反式-4-(马来酰亚胺甲基)环... 71875-81-5 |
文献:Leonard, Nicholas M.; Brunckova, Jarmila Journal of Organic Chemistry, 2011 , vol. 76, # 21 p. 9169 - 9174 |
~% 反式-4-(马来酰亚胺甲基)环... 71875-81-5 |
文献:Leonard, Nicholas M.; Brunckova, Jarmila Journal of Organic Chemistry, 2011 , vol. 76, # 21 p. 9169 - 9174 |
~% 反式-4-(马来酰亚胺甲基)环... 71875-81-5 |
文献:Leonard, Nicholas M.; Brunckova, Jarmila Journal of Organic Chemistry, 2011 , vol. 76, # 21 p. 9169 - 9174 |
~% 反式-4-(马来酰亚胺甲基)环... 71875-81-5 |
文献:Nielsen; Buchardt Synthesis, 1991 , # 10 p. 819 - 821 |
反式-4-(马来酰亚胺甲基)环己烷羧酸-NHS上游产品 6 | |
---|---|
反式-4-(马来酰亚胺甲基)环己烷羧酸-NHS下游产品 0 |
海关编码 | 2925190090 |
---|---|
中文概述 | 2925190090 其他酰亚胺及其衍生物盐. 增值税率:17.0% 退税率:9.0% 监管条件:无 最惠国关税:6.5% 普通关税:30.0% |
申报要素 | 品名, 成分含量, 用途 |
Summary | 2925190090 other imides and their derivatives; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0% |
Succinimidyl p-hydroxymethyl benzoate |
1-[(4-{[(2,5-Dioxopyrrolidin-1-yl)oxy]carbonyl}cyclohexyl)methyl]-1H-pyrrole-2,5-dione |
1H-Pyrrole-2,5-dione, 1-((4-(((2,5-dioxo-1-pyrrolidinyl)oxy)carbonyl)cyclohexyl)methyl)- |
1-[(4-{[(2,5-Dioxo-1-pyrrolidinyl)oxy]carbonyl}cyclohexyl)methyl]-1H-pyrrole-2,5-dione |
1H-pyrrole-2,5-dione, 1-[[4-[[(2,5-dioxo-1-pyrrolidinyl)oxy]carbonyl]cyclohexyl]methyl]- |
Trans-4-(Maleimidomethyl)cyclohexanecarboxylic Acid-NHS |
1H-Pyrrole-2,5-dione, 1-[[trans-4-[[(2,5-dioxo-1-pyrrolidinyl)oxy]carbonyl]cyclohexyl]methyl]- |
1-[(trans-4-{[(2,5-Dioxo-1-pyrrolidinyl)oxy]carbonyl}cyclohexyl)methyl]-1H-pyrrole-2,5-dione |
trans-Cyclohexanecarboxylic Acid 4-[(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)methyl]-,2,5-dioxo-1-pyrrolidinyl ester |
succinimidyl trans-4(maleimidylmethyl)-cyclohexane-1-carboxylate |
2,5-Pyrrolidinedione,1-[[4-(hydroxymethyl)benzoyl]oxy] |